Clinical Trial Update: OPTION 2: A Trial to Assess the Safety and Efficacy of MS1819 in Enteric Capsules in Patients With Cystic Fibrosis [Phase 2]

View source ↗

Summary

Phase 2 trial update for MS1819 in enteric capsules evaluating safety and efficacy in Exocrine Pancreatic Insufficiency and Cystic Fibrosis; study completed wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis
• Exocrine Pancreatic Insufficiency

Drugs mentioned

• MS1819 (MS1819)

Snippet

Sponsor: Entero Therapeutics | Conditions: Exocrine Pancreatic Insufficiency (EPI), Cystic Fibrosis (CF) | Phase 2 | Status: COMPLETED | Results posted: 2022-09-13